Profile
SXTP VRTX REGN VRNA ARGX ALNY
Company Name 60 Degrees Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.19M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Geoffrey Stuart Dow Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SXTP VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SXTP VRTX REGN VRNA ARGX ALNY
Last Close $1.02 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.45 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.45 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -70.43 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 126.67 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SXTP VRTX REGN VRNA ARGX ALNY
1 Month Return -31.54 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -21.54 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -58.7 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 95.25 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -20.93 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 10.87 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SXTP VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -104.7 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SXTP VRTX REGN VRNA ARGX ALNY
Asset Growth -26.01 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 200.83 % 1.16 % - 26.81 %
Revenue Growth 139.61 % 0.99 % - 22.97 %
Revenue 3 Year 565.98 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year 254.26 % 73.64 % - 775.72 %
Revenue 10 Year 254.26 % 285.02 % - 2487.4 %
EBIT Growth -420.49 % 9.09 % -131.37 % 24.59 %
Net Income Growth -111.04 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -2277.33 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -3231.8 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -3231.8 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -88.47 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -24.33 % - -143.33 % -107.98 %
Operating 3 Year CFG -10967.11 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -42839.45 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -42839.45 % -100 % 40.15 % 97.08 %
EPS Growth -1852.63 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -1852.63 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 618.11 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 392 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 393.28 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 393.28 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -9.72 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -25.12 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SXTP VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 19.14 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -119.24 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -212.63 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -176.25 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 99.99 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.76 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -821.68 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -4418.97 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 1.43 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.56 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 1.48 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 423.06 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 14.4 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -7.39 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -7.47 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 447.93 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -705.2 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.96 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -4418.97 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.46 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.53 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.53 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
SXTP VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 36.67% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -74.2 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
SXTP VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
SXTP VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.345
AARD Aardvark Therapeutics, Inc. Common Stock 12.27
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.995
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.395
ABPWW 0.0131
ABSI Absci Corporation 2.415
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.35
ACAD ACADIA Pharmaceuticals Inc. 21.605
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.74
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to SXTP
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 213.895
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.55
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.56
VEMPX Vanguard Extended Market Index InstlPlus 0 408.54
Unlock